Le formulazioni long term dei farmaci agonisti nella clinica del disturbo da uso di oppiacei in Italia

Journal title MISSION
Author/s Marco Riglietta, Pietro Fausto D’Egidio, Alfio Lucchini, Nicoletta D’Aloisio, Maria Luisa Buzzi
Publishing Year 2020 Issue 2020/53
Language Italian Pages 20 P. 45-64 File size 0 KB
DOI 10.3280/mis53-2020oa9860
DOI is like a bar code for intellectual property: to have more infomation click here

View article Download Open Access article

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

  • Exploring the Italian Experience with Long-Acting Buprenorphine Formulations (LAIB) for the Treatment of Opioid Use Disorder: A Series of Narrative Interviews Vincenza Ariano, Anna Francesca Costanzo, Gemma Ferrante, Rossella Garofano, Vincenzo Lamartora, Sergio Manfré, Deborah Nordici, Lorenzo Somaini, in International Journal of Environmental Research and Public Health /2026 pp.336
    DOI: 10.3390/ijerph23030336
  • Weekly long-acting buprenorphine for opioid use disorder in the custody setting: An italian experience Dimosthenis Karonis, in Heroin Addiction and Related Clinical Problems 2/2025 pp.1
    DOI: 10.62401/2531-4122-2025-28

Marco Riglietta, Pietro Fausto D’Egidio, Alfio Lucchini, Nicoletta D’Aloisio, Maria Luisa Buzzi, Le formulazioni long term dei farmaci agonisti nella clinica del disturbo da uso di oppiacei in Italia in "MISSION" 53/2020, pp 45-64, DOI: 10.3280/mis53-2020oa9860